Effects of erythropoietin on fibroblast growth factor 23 in mice and humans

BACKGROUND: Erythropoietin (EPO) has been reported as a novel determinant of fibroblast growth factor 23 (FGF23) production; however, it is unknown whether FGF23 is stimulated by chronic exposure to EPO or by EPO administration in nonpolycystic chronic kidney disease (CKD) models. METHODS: We analyz...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Nephrol Dial Transplant
Autores principales: Hanudel, Mark R, Eisenga, Michele F, Rappaport, Maxime, Chua, Kristine, Qiao, Bo, Jung, Grace, Gabayan, Victoria, Gales, Barbara, Ramos, Georgina, de Jong, Maarten A, van Zanden, Jelmer J, de Borst, Martin H, Bakker, Stephan J L, Nemeth, Elizabeta, Salusky, Isidro B, Gaillard, Carlo A J M, Ganz, Tomas
Formato: Artigo
Lenguaje:Inglês
Publicado: Oxford University Press 2019
Materias:
ORIGINAL ARTICLES
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6888066/
https://ncbi.nlm.nih.gov/pubmed/30007314
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ndt/gfy189
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares